Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial.

MLA

Papi, Alberto, et al. “Regular versus As-Needed Budesonide and Formoterol Combination Treatment for Moderate Asthma: A Non-Inferiority, Randomised, Double-Blind Clinical Trial.” The Lancet. Respiratory Medicine, vol. 3, no. 2, Feb. 2015, pp. 109–19. EBSCOhost, https://doi.org/10.1016/S2213-2600(14)70266-8.

APA

Papi, A., Marku, B., Scichilone, N., Maestrelli, P., Paggiaro, P., Saetta, M., Nava, S., Folletti, I., Bertorelli, G., Bertacco, S., Contoli, M., Plebani, M., Barbaro, M. P. F., Spanevello, A., Aliani, M., Pannacci, M., Morelli, P., Beghé, B., & Fabbri, L. M. (2015). Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial. The Lancet. Respiratory Medicine, 3(2), 109–119. https://doi.org/10.1016/S2213-2600(14)70266-8

Chicago

Papi, Alberto, Brunilda Marku, Nicola Scichilone, Piero Maestrelli, Pierluigi Paggiaro, Marina Saetta, Stefano Nava, et al. 2015. “Regular versus As-Needed Budesonide and Formoterol Combination Treatment for Moderate Asthma: A Non-Inferiority, Randomised, Double-Blind Clinical Trial.” The Lancet. Respiratory Medicine 3 (2): 109–19. doi:10.1016/S2213-2600(14)70266-8.